Literature DB >> 11175324

Analysis of human endothelial cells and cortical neurons for susceptibility to HIV-1 infection and co-receptor expression.

G D Kanmogne1, P Grammas, R C Kennedy.   

Abstract

Neuronal cell death is believed to be the underlying cause of neurological diseases and AIDS dementia often seen in human immunodeficiency virus (HIV) infected patients. The means by which HIV invades the brain is still unknown and the mechanism of neuronal cell death remains to be elucidated. The aim of this study was to determine if direct infection of human brain endothelial cells and neurons play a role in viral invasion of the brain and neuronal cell death, respectively. To this effect, we evaluated human brain microvascular endothelial cells (HBMEC) and human cortical neurons (HCN) for the expression of HIV co-receptors and their susceptibility to HIV-1 infection. While both HBMEC and HCN failed to express any CXCR4 and CCR5 on their cell surface, as assessed by flow cytometry, RT - PCR revealed the presence of CXCR4 and CCR5 mRNA in HBMEC but not in HCN. Two dual tropic HIV-1 primary isolates failed to infect both cell types as determined by p24 antigen capture ELISA, RT - PCR and DNA PCR. These data support the hypothesis that no productive infection of HBMEC and HCN occurs in vitro and suggest that other cell types are the primary focus of HIV-1 infection in the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175324     DOI: 10.3109/13550280009091952

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  9 in total

Review 1.  HIV-associated neurodegeneration: exploitation of the neuronal cytoskeleton.

Authors:  Erin D Wenzel; Valeria Avdoshina; Italo Mocchetti
Journal:  J Neurovirol       Date:  2019-03-08       Impact factor: 2.643

2.  Cross-talk between STAT1 and PI3K/AKT signaling in HIV-1-induced blood-brain barrier dysfunction: role of CCR5 and implications for viral neuropathogenesis.

Authors:  Bo Yang; Sangya Singh; Rafael Bressani; Georgette D Kanmogne
Journal:  J Neurosci Res       Date:  2010-11-01       Impact factor: 4.164

Review 3.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 4.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

5.  Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  Virol J       Date:  2011-08-10       Impact factor: 4.099

6.  Histone deacetylase 6 inhibition rescues axonal transport impairments and prevents the neurotoxicity of HIV-1 envelope protein gp120.

Authors:  Erin D Wenzel; Andrew Speidell; Sarah A Flowers; Chengbiao Wu; Valeria Avdoshina; Italo Mocchetti
Journal:  Cell Death Dis       Date:  2019-09-12       Impact factor: 8.469

7.  CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium.

Authors:  Carolina Estevao; Chantelle E Bowers; Ding Luo; Mosharraf Sarker; Alexandra Eva Hoeh; Karen Frudd; Patric Turowski; John Greenwood
Journal:  Brain Behav Immun Health       Date:  2021-10-22

8.  HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions: modulatory role of CCR5.

Authors:  Shawna M Woollard; Hong Li; Sangya Singh; Fang Yu; Georgette D Kanmogne
Journal:  Retrovirology       Date:  2014-02-26       Impact factor: 4.602

9.  Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection.

Authors:  Silvia Torices; Rosalba Cabrera; Michael Stangis; Oandy Naranjo; Nikolai Fattakhov; Timea Teglas; Daniel Adesse; Michal Toborek
Journal:  J Neuroinflammation       Date:  2021-07-29       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.